Moderna released a press release Wednesday touting its Omicron injection, but admitted that the "Shot elicited a weaker response versus BA.4 and BA.5," according to Reuters.
The Massachusetts-based biotech company drove tons of positive press for its preliminary findings that were released a couple of weeks ago, ostensibly showing that the Omicron booster performed better than the original shot.
As for how many Omicron shots you should take in addition to your 4 to 5 older injections, Moderna hasn't yet nailed down "The science" on that either.
You can't help but notice the overly cautious language from Moderna's CMO. The Omicron shot has been in development for several months.
Moderna has settled on a shot designed for the no longer existent BA.1 sub variant.
Moderna is projecting an estimated $15 billion in profit this year, driven entirely by its only product on the market: an expired and worthless COVID shots, and a soon to come expired and worthless COVID shot.
Surely, the Omicron shot will cost taxpayers even more, much to the delight the several newfound billionaires who serve atop Moderna's c-suite.
https://dossier.substack.com/p/already-expired-modernas-upcoming
No comments:
Post a Comment